Biotech investors lose money despite positive year as XBI index declines
Many biotech investors are experiencing losses in 2025 despite what appears to be a positive year on the surface, with trouble brewing on Wall Street for the sector. The decline comes even as dozens of biotechs went public this year and small-cap stocks slide into correction territory.
